Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.).
Díaz-Rubio E, Jimeno J, Antón A, Aranda E, Sánchez J, Massuti B, Cruz-Hernández J, Carrato A, Martin M, Belón J, et al. Díaz-Rubio E, et al. Among authors: massuti b. Am J Clin Oncol. 1992 Feb;15(1):56-60. doi: 10.1097/00000421-199202000-00011. Am J Clin Oncol. 1992. PMID: 1550080 Clinical Trial.
Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.).
Díaz-Rubio E, Jimeno J, Aranda E, Massuti B, Camps C, Cervantes A, Dorta J, Cruz Hernández JJ, Dominguez S, Anton A, et al. Díaz-Rubio E, et al. Among authors: massuti b. Ann Oncol. 1992 Dec;3(10):861-3. doi: 10.1093/oxfordjournals.annonc.a058113. Ann Oncol. 1992. PMID: 1286050 Free article. Clinical Trial.
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society).
Villar-Grimalt A, Aranda E, Massutí B, Belón J, Antón A, Jimeno JM, Candel MT, García de Paredes ML, Colajori E. Villar-Grimalt A, et al. Among authors: massuti b. Tumori. 1994 Apr 30;80(2):124-7. doi: 10.1177/030089169408000207. Tumori. 1994. PMID: 8016902 Clinical Trial.
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Cervantes A, Villar-Grimalt A, Abad A, Antón-Torres A, Belón J, Dorta J, Tres A, Camps C, Fonseca E, Massutí B, et al. Cervantes A, et al. Among authors: massuti b. Ann Oncol. 1993 Nov;4(9):753-7. doi: 10.1093/oxfordjournals.annonc.a058660. Ann Oncol. 1993. PMID: 8280656 Free article. Clinical Trial.
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.
Cardenal F, López-Cabrerizo MP, Antón A, Alberola V, Massuti B, Carrato A, Barneto I, Lomas M, García M, Lianes P, Montalar J, Vadell C, González-Larriba JL, Nguyen B, Artal A, Rosell R. Cardenal F, et al. Among authors: massuti b. J Clin Oncol. 1999 Jan;17(1):12-8. doi: 10.1200/JCO.1999.17.1.12. J Clin Oncol. 1999. PMID: 10458212 Clinical Trial.
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.
Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT, Albanell J, Aranda J, Munarriz B, Campbell J, Diaz-Rubio E; GEICAM Group (Spanish Breast Cancer Research Group), Spain. Martin M, et al. Among authors: massuti b. Ann Oncol. 2003 Jun;14(6):833-42. doi: 10.1093/annonc/mdg260. Ann Oncol. 2003. PMID: 12796019 Free article. Review.
First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).
Sastre J, Aranda E, Grávalos C, Massutí B, Varella-Garcia M, Rivera F, Soler G, Carrato A, Manzano JL, Díaz-Rubio E, Hidalgo M. Sastre J, et al. Among authors: massuti b. Crit Rev Oncol Hematol. 2011 Jan;77(1):78-84. doi: 10.1016/j.critrevonc.2009.11.005. Epub 2009 Dec 29. Crit Rev Oncol Hematol. 2011. PMID: 20042346 Clinical Trial.
196 results